Histidine

Histidine

SCHEMBL949906

NC(CCc1c[nH]cn1)C(=O)O.N[C@@H](Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 3/20 0.41
CYP3A4 P08684 1/20 0.41
CYP1A2 P05177 2/20 0.40
GRIA1 P42261 2/20 0.39
GRIA2 P42262 2/20 0.39
GRIA3 P42263 2/20 0.39
GRIA4 P48058 2/20 0.39
GRIK1 P39086 1/20 0.39
GRIK2 Q13002 1/20 0.39
GRIK3 Q13003 1/20 0.39
GRM2 Q14416 2/20 0.38
GRM6 O15303 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP2C9 P11712 1/20 0.38
ALOX15 P16050 1/20 0.38
CYP2C19 P33261 1/20 0.38
ARG1 P05089 1/20 0.37
ALPI P09923 1/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29805439 0.94 GRM2 (0.42) SLC7A5CYP3A4CYP1A2GRIA1GRIA2
SCHEMBL951906 0.94 GRM2 (0.42) SLC7A5CYP3A4CYP1A2GRIA1GRIA2
SCHEMBL21689931 0.94 GRM2 (0.42) SLC7A5CYP3A4CYP1A2GRIA1GRIA2
Histidine SCHEMBL3258 0.91 SLC7A5 (0.47) SLC7A5CYP3A4CYP1A2GRIA1GRIA2
Histidine SCHEMBL8080341 0.91 SLC7A5 (0.47) SLC7A5CYP3A4CYP1A2GRIA1GRIA2
Histidine SCHEMBL3259 0.91 SLC7A5 (0.47) SLC7A5CYP3A4CYP1A2GRIA1GRIA2
Histidine SCHEMBL163442 0.91 SLC7A5 (0.47) SLC7A5CYP3A4CYP1A2GRIA1GRIA2
Histidine SCHEMBL995910 0.91 SLC7A5 (0.47) SLC7A5CYP3A4CYP1A2GRIA1GRIA2
Histidine SCHEMBL388563 0.91 SLC7A5 (0.47) SLC7A5CYP3A4CYP1A2GRIA1GRIA2
Histidine SCHEMBL163443 0.91 SLC7A5 (0.47) SLC7A5CYP3A4CYP1A2GRIA1GRIA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021483-A1 Platinum (IV) Complexes PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021483-A1 Platinum (IV) Complexes OTC, OAT, SLC25A11 SLC7A5 379/4885CYP3A4 788/4885CYP1A2 3419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.